Logo

Do you have a project in your
mind? Keep connect us.

Contact Us

  • +44 454 7800 112
  • infotech@arino.com
  • 50 Wall Street Suite, 44150 Ohio, United States

Subscribe

At vero eos et accusamus et iusto odio as part dignissimos ducimus qui blandit.

Advancing Leaders in Biotech,
Life Sciences & Healthcare

About

The Excellentium. – The World’s International, Inter-Generational Leadership Summit Addressing The Gaps In The Biotechnology Sector

Following the success of our flagship annual event the GapSummit – The Excellentium is designed to tackle the current gap in leadership skills in the biotech and healthcare ecosystem by providing 100 outstanding participants from STEM backgrounds with the necessary tools and resources to spearhead the development of the global ecosystem.

We are looking for high-achieving, ambitious individuals from all over the world that aspire to take on leadership positions in their communities and advance their careers to make real-world impact. Excellentium applicants should be highly motivated, outside-of-the-box thinkers, with core leadership attributes, willing to learn from, engage with and challenge current leaders with the goal of creating positive impact in their professional field.

Applications for Excellentium 2026 are now closed.

Format

Academy

Virtual Academy

The Virtual Academy aims at providing our participants with the tools and resources to become leaders in their fields and communities through a series of online masterclasses and guided self-learning. It focuses on 8 key learning areas: communication, negotiation, adaptation, culture, style, links, scales and ethics. The weekly time commitment for the Excellentium Virtual Academy is expected to be: - 45 minutes for the live masterclasses (please note the masterclasses are also recorded and made available after the live session); ~ 2-3 hours for the curated content that participants can go through at their own pace.

Forum

Forum

Participants will engage with world-renowned leaders in biotech, healthcare, and life sciences. We will bring together a diverse range of ecosystem stakeholders, including politicians, executives, founders, policymakers, and journalists. The Forum is built around three core pillars: Strategy, Management and Execution. The Forum will take place from the 7th to the 9th of July 2026, at Emlyon Business School in Lyon, France.

Speakers

Dr. Thierry Abribat

Former Founder & CEO, Amolyt Pharma

Hervé Affagard

Founder and CEO, MaaT Pharma

Karen Akinsanya

President, R&D - Therapeutics & Chief Strategy Officer, Schrödinger

Shreeram Aradhye

President, Development and Chief Medical Officer, Novartis

Dr. Sujuan Ba

President & CEO, National Foundation for Cancer Research

Trine Bartholdy

Chief Business Officer, BioInnovation Institute

Tarquin Bennett-Coles

Director of the Life Sciences Practice, Compass Carter Osborne

Thierry Bernard

Chief Executive Officer and Managing Director, QIAGEN

Dr. Henrik Björkman

Vice President R&D, Thermo Fisher Scientific

Dr. Chris Booth

Chief Executive Officer, FYR Bio

David Booth

VP of Business Development and Co-Founder, FYR Bio

Dr. Celine Bouquet

Head of BD, Neuroscience, Ophthalmology and Rare Diseases, Roche

Dr. Zuzanna Brzosko

Chief Business Officer, Integrated Biosciences

Valérie Calenda

Managing Partner, Merieux Equity Partners

Alexis Capelle

Founder & CEO, BTHT

Prof. Marina Cavazzana

Professor of Hematology, Paris-Cité University | Head of Biotherapy, Necker Hospital

Fabrice Chouraqui

CEO & Executive Director, Pharming

Dr. Laia Crespo

Partner, Sanofi Ventures

Paul-Alan Dollinger

Directeur Général Délégué, Sanofi Vaccines

Rémi Droller

Managing Partner, Kurma Partners

Pierre d'Epenoux

Biotech CEO & Board member

Nienke Feenstra

General Manager, Takeda France

Regis Gervier

Global Head | mRNA Center of Excellence | Sanofi

Elisabeth Guy-Dubois

Partner, Talent Management, Executive Coach, Oasys & Cie I Diot Siaci

Delphine Guyon-Gellin

CBDO & COO, Osivax

Hervé Hoppenot

Advisor to CEO, INCYTE

Dr. Adelina Ivanova

PostDoc, Novartis

Dr. Dylan Kissane

General Manager, Labiotech | Founder, Scriblr

Patrick Loustau

President and CEO, Granite Bio

Dr. Johan Luthman

EVP & Head of R&D, Lundbeck

Alexandre Mérieux

Président, Biomérieux

Dr. Navraj Nagra

Associate Partner, McKinsey & Company

Jack O’Meara

Chief Executive Officer, Aerska

Dr. Francisca Peixoto

Co-Founder & Managing Partner, LifeLink Ventures

Dr. Cesar Sanz Rodriguez

Vice President, Medical Affairs, Amgen

Dr. Ruth Shah

Head of Bayer Co.Lab Berlin, Bayer

Nigel Sheail

Partner, Versant Ventures

Dr. Andrew Singleton

Lead, Global Parkinson’s Genetics Program

Oliver Soula

CEO, Adocia

Felice Verduyn - van Weegen

Partner, EQT Group

Prof. Bruno Versaevel

Head of the Healthcare Innovation, Technology & Society (HITS) Institute

Alexandre Le Vert

Co-founder and CEO, Osivax

Dr. Dana Vigier

Presidente & Directrice Generale, France & BeLux, Alexion

Jacques Volckmann

Vice President R&D France and Global Head of External Innovation, Sanofi

Dan Vulcanescu

President, Global Biotech Revolution

Nicky Wojtania

Global Biotech Revolution

Dr. Zhizhong Joel Yao

Partner, Sofinnova Partners

Dr. Alexandra Zemp

Partner, McKinsey & Company

Featured Contributors

Dr. Umar Adegoke

Associate, BioInnovation Institute

Dr. Claudio Battilocchio

Global Head of Digital Automation R&D, Syngenta Crop Protection

Teddy Breyton

General Manager, Lyonbiopôle

Prisca Dalle

Head of Inward Investments, ONLYLYON & CO

Guilhaume Debroas

Head of Corporate Development, MaaT Pharma

Paul Desert

Head of Non-Clinical Safety & Predictive Sciences, Sanofi R&D Vaccins

Laurence Festor

Head of Operations - Digital M&S Accelerator, Sanofi

Mathieu Fontaine

Head of Strategy and Business Intelligence, MaaT Pharma

Dr. Isabelle Fugier

Head Vaccines R&D Partnerships & Stakeholders Engagement in France, Sanofi

Bruno Gagliardo

Head of Data and Artificial Intelligence, Sanofi

Florent Gerbaud

Lead Advisor Life Sciences, OnlyLyon Invest

Lila d'Hermies

Corporate Relations Manager, emlyon Business School

Francois Lacoste

EVP Medical & Scientific Affaires, Institut Mérieux

Vanina Laurent-Ledru

Chief Public Health and Government Affairs Officer, Institut Mérieux & bioMérieux

Aurelie Lezer Auffret

Talent Acquisition Lead, Sanofi

Dr. Quentin Le Masne

Adjunct Professor, emlyon

Dr. Christine Prost

Novel Translational Model Lead, Sanofi

Kevin Romani

COO, Lyonbiopôle Auvergne-Rhône-Alpes

Ludivine Toutounji

Directrice Partenariats Entreprise, emlyon

Watch the Excellerator 2023

Our reputed world wide partners
Our reputed world wide partners